BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help
Search Results
Documents 1-3 out of 3 found
  Current Search:  elaprase: 3     
HTML
100%
Costly drugs give ailing boy hope
Szymon Cajmer, 12, suffers from a crippling condition known as Hunter Syndrome, or MPS II, which is caused by an enzyme deficiency and affects about 40 people in Canada and only about six in Ontario.

Szymon's organs are enlarged, his heart...

Checkbiotech:  Sep 8 2008 1:43PM
Matching: elaprase 		Find similar documents
HTML
100%
Free access to Elaprase
The Hunter syndrome drug Elaprase, marketed by Genzyme Australasia, will be funded by the federal government under its life saving drugs program.

Hunter syndrome, or Mucopolysaccharidosis II, is a rare inherited enzyme disorder is...

Biotechnology News:  Sep 5 2008 8:34AM
Matching: elaprase 		Find similar documents
HTML
100%
Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgra
/PRNewswire-FirstCall/ -- Shire Limited the global specialty biopharmaceutical company announces results for the three months to June 30, 2008.

BASINGSTOKE, England and PHILADELPHIA, July 31, 2008 /PRNewswire-FirstCall/ -- Shire Limited...

Pharma Live:  Jul 31 2008 1:38PM
Matching: elaprase 		Find similar documents
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.